Acorda Therapeutics, Inc.
ACORQ
Price:
$0.01
Market Cap:
$821.03K
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in adults with multiple sclerosis; and Inbrija, an inhaled levodopa for intermittent treatment of OFF periods in people with Parkinson's disease treated with a carbidopa/levodopa regimen. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, it has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. The company was incorporated in 1995 and is headquartered in Pearl River, New York. On April 1, 20...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-02-10
Stock Exchange
OTC
Ticker
ACORQ
PE Ratio
[-0.00]
ROE
[786.07%]
Current Ratio
[0.33]
Dividend Yield
[0%]
Enterprise Value
[161.36M]
Dividend History
The ROE as of November 2025 (TTM) for Acorda Therapeutics, Inc. (ACORQ) is 786.07%
According to Acorda Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 786.07%. This represents a change of 2.44% compared to the average of 30.93% of the last 4 quarters.
Acorda Therapeutics, Inc. (ACORQ) Historical ROE (quarterly & annually)
How has ACORQ ROE performed in the past?
The mean historical ROE of Acorda Therapeutics, Inc. over the last ten years is -14.64%. The current 786.07% ROE has changed -5468.53% with respect to the historical average. Over the past ten years (40 quarters), ACORQ's ROE was at its highest in in the December 2023 quarter at 137.86%. The ROE was at its lowest in in the September 2019 quarter at -93.67%.
Average
-14.64%
Median
-23.57%
Minimum
-87.82%
Maximum
160.08%
Acorda Therapeutics, Inc. (ACORQ) ROE by Quarter and Year
Discovering the peaks and valleys of Acorda Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 711.88%
Maximum Annual ROE = 160.08%
Minimum Annual Increase = -1695.66%
Minimum Annual ROE = -87.82%
| Year | ROE | Change |
|---|---|---|
| 2023 | 160.08% | -327.36% |
| 2022 | -70.41% | 2.36% |
| 2021 | -68.78% | 64.34% |
| 2020 | -41.85% | -52.34% |
| 2019 | -87.82% | -1695.66% |
| 2018 | 5.50% | -112.81% |
| 2017 | -42.95% | 711.88% |
| 2016 | -5.29% | -388.52% |
| 2015 | 1.83% | -43.94% |
| 2014 | 3.27% | -12.39% |
Acorda Therapeutics, Inc. (ACORQ) Average ROE
How has ACORQ ROE performed in the past?
The current ROE of Acorda Therapeutics, Inc. (ACORQ) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.96%
5-year avg
-21.76%
10-year avg
-14.64%
Acorda Therapeutics, Inc. (ACORQ) ROE vs. Peers
How is ACORQ’s ROE compared to its peers?
Acorda Therapeutics, Inc.’s ROE is greater than Goodbody Health Limited (-34.66%), less than New You, Inc. (288.53%), less than Advanzeon Solutions, Inc. (0%), greater than Genesis Healthcare, Inc. (7.46%), greater than MagForce AG (-33.92%), greater than Hempfusion Wellness Inc. (0%), less than NutraLife BioSciences, Inc. (2.83%), less than Navidea Biopharmaceuticals, Inc. (355.34%), less than Nanomix Corporation (128.37%), less than Generex Biotechnology Corporation (216.76%),
| Company | ROE | Market cap |
|---|---|---|
| -34.66% | $365.00 | |
| 288.53% | $14.99K | |
| 0% | $11.99K | |
| 7.46% | $12.15K | |
| -33.92% | $11.97K | |
| 0% | $1.64K | |
| 2.83% | $17.66K | |
| 355.34% | $10.01K | |
| 128.37% | $9.80K | |
| 216.76% | $0 |
Build a custom stock screener for Acorda Therapeutics, Inc. (ACORQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acorda Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Acorda Therapeutics, Inc. (ACORQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Acorda Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Acorda Therapeutics, Inc.'s ROE?
How is the ROE calculated for Acorda Therapeutics, Inc. (ACORQ)?
What is the highest ROE for Acorda Therapeutics, Inc. (ACORQ)?
What is the 3-year average ROE for Acorda Therapeutics, Inc. (ACORQ)?
What is the 5-year average ROE for Acorda Therapeutics, Inc. (ACORQ)?
How does the current ROE for Acorda Therapeutics, Inc. (ACORQ) compare to its historical average?